Growth inhibition of the pulmonary metastatic tumors by systemic delivery of the p27kip1 gene using lyophilized lipid-polycation-DNA complexes

Journal of Gene Medicine

Volumn 11, Issue 6, 2009, Pages 535-544

  Sun, Xun ^a   Zhang, Hong Wei ^a   Zhang, Zhi Rong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Cancer therapy; Gene delivery; Lung cancer; Nonviral vector; Polycations

Indexed keywords

CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DRUG CARRIER; EOSIN; HEMATOXYLIN; LIPID POLYCATION DNA COMPLEX; LIPOSOME; NAKED DNA; PHOSPHATE BUFFERED SALINE; PLASMID DNA; PROTAMINE SULFATE; UNCLASSIFIED DRUG; LIPOSOME POLYCATION DNA COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; CANCER GENE THERAPY; CANCER INHIBITION; CELL CYCLE PROGRESSION; COLON ADENOCARCINOMA; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; FREEZE DRYING; GENE CONSTRUCT; GENE EXPRESSION; GENE IDENTIFICATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INOCULATION; LIFESPAN; LUNG METASTASIS; METASTASIS; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RECOMBINANT PLASMID; STAINING; TUMOR MODEL; TUMOR SUPPRESSOR GENE; ANIMAL CELL; TUMOR GROWTH;

ANIMALIA; MUS;

ANIMALS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DNA; FEMALE; FREEZE DRYING; GENE THERAPY; GENETIC VECTORS; IMMUNOHISTOCHEMISTRY; LIPOSOMES; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; POLYAMINES; TRANSFECTION;

EID: 65949102988     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1322     Document Type: Article

References (34)

1. Coats S, Flanagan WM, Nourse J, Roberts JM. Requirement of p27 kip1 for restriction point control of the fibroblast cell cycle. Science 1996; 272: 877-880.
2. Clurman BE, Porter P. New insights into tumor suppression function of p27Kip1. Proc Natl Acad Sci USA 1998; 95: 15158-15160.
3. Fero ML, Rivkin M, Tasch M, et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27 (Kip1)-deficient mice. Cell 1996; 85: 733-744.
4. Nakayama K, Ishida N, Shirane M, et al. Mice lacking p27 (Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996; 85: 707-720.
5. Fero ML, Randel E, Gurley KE, Roberts JM, Kemp CJ. The murine gene p27Kip1 is haplo-insufficient for tumor suppression. Nature 1998; 396: 177-180.
6. Belletti B, Nicoloso MS, Schiappacassi M, et al. p27 kip1 functional regulation in human cancer: a potential target for therapeutic designs. Curr Med Chem 2005; 12: 1589-1605.
7. Slingerland J, Pagano M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol, 2000; 183: 10-17.
8. Philipp-Staheli J, Payne SR, Kemp CJ. p27 (Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Exp Cell Res 2001; 264: 148-168.
9. Lloyd RV, Jin L, Qian X, Kulig E. Aberrant p27 kip1 expression in endocrine and other tumors. Am J Pathol 1997; 150: 401-407.
10. Park KH, Lee J, Yoo CG, et al. Application of p27 gene therapy for human malignant glioma potentiated by using mutant p27. J Neurosurg 2004; 101: 505-510.
11. Naruse I, Hoshino H, Dobashi K, Minato K, Saito R, Mori M. Over-expression of p27 kip1 induces growth arrest and apoptosis mediated by changes of pRb expression in lung cancer cell lines. Int J Cancer 2000; 88: 377-383.
12. Ishii T, Fujishiro M, Masuda M, et al. Effects of p27Kip1 on cell cycle status and viability in A549 lung adenocarcinoma cells. Eur Respir J 2004; 23: 665-670.
13. Supriatno, Harada K, Kawaguchi S, Onoue T, Yoshida H, Sato M. Characteristics of antitumor activity of mutant type p27Kip1 gene in an oral cancer cell line. Oral Oncol 2004; 40: 679-687.
14. Craig C, Wersto R, Kim M, et al. A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells. Oncogene 1997; 14: 2283-2289.
15. Katner AL, Hoang QB, Gootam P, et al. Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27 (Kip1). Prostate 2002; 53: 77-87.
16. Park KH, Seol JY, Yoo CG, et al. Adenovirus expressing p27 (Kip1) induces growth arrest of lung cancer cell lines and suppresses the growth of established lung cancer xenografts. Lung Cancer 2001; 31: 149-155.
17. Zhang WG, Wu QM, Yu JP, et al. Adenovirus expressing p27 kip1 suppresses growth of established esophageal carcinoma xenografts. World J Gastroenterol 2005; 11: 6582-6586.
18. Eto Y, Yoshioka Y, Mukai Y, Okada N, Nakagawa S. Development of PEGylated adenovirus vector with targeting ligand. Int J Pharm 2008; 354: 3-8.
19. Price AR, Limberis MP, Wilson JM, Diamond SL. Pulmonary delivery of adenovirus vector formulated with dexamethasone-spermine facilitates homologous vector re-administration. Gene Ther 2007; 14: 1594-1604.
20. Liu Y, Mounkes LC, Liggitt HD, et al. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nat Biotechnol 1997; 15: 167-173.
21. Li S, Rizzo MA, Bhattacharya S, Huang L. Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery. Gene Ther 1998; 5: 930-937.
22. Templeton NS, Lasic DD, Frederik PM, Strey HH, Roberts DD, Pavlakis GN. Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol 1997; 15: 647-652.
23. The International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004; 350: 351-360.
24. Sun X, Hai L, Wu Y, Hu HY, Zhang ZR. Targeted gene delivery to hepatoma cells using galactosylated liposome-polycation-DNA complexes (LPD). J Drug Target 2005; 13: 121-128.
25. Zhang L, Sun X, Zhang HW, Sang YY, Yi T, Qiao SY. The construction, characterization and transfection of liposomepolycation-CDKN1B plasmid complexes. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2005; 22: 24-28.
26. Li B, Li S, Tan Y, et al. Lyophilization of cationic lipid-protamine-DNA (LPD) complexes. J Pharm Sci 2000; 89: 355-364.
27. Li SD, Huang L. Non viral is superior to viral gene delivery. J Control Release 2007; 123: 181-183.
28. Sakurai F, Terada T, Maruyama M, et al. Therapeutic effect of intravenous delivery of lipoplexes containing the interferon-β gene and poly I: poly C in a murine lung metastasis model. Cancer Gene Ther 2003; 10: 661-668.
29. Dow SW, Elmslie RE, Fradkin LG, et al. Intravenos cytokine gene delivery by lipid-DNA complexes control the growth of established lung metastases. Hum Gene Ther 1999; 10: 2961-2972.
30. Whitmore M, Li S, Huang L. LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth. Gene Ther 1999; 6: 1867-1875.
31. Kelland LR. New platinum antitumor complexes. Critical Rev Oncol Hematol 1993; 15: 191-219.
32. Kartalou M, Essigmann JM. Mechanisms of resistance to cisplatin. Mutat Res 2001; 478: 23-43.
33. Zhang Q, Tian L, Mansouri A, Korapati AL, Johnson TJ, Claret FX. Inducible expression of a degradation-resistant form of p27 kip1 causes growth arrest and apoptosis in breast cancer cells. FEBS Lett, 2005; 579: 3932-3940.
34. Sasaki T, Katayose Y, Yamamoto K, et al. Adenovirus expressing mutant p27 kip1 enhanced apoptosis and inhibited the growth of xenografted human breast cancer. Surg Today 2007; 37: 1037-1082.